Success Story: O-1A and EB-1A Under Premium Processing! How We Helped a Molecular Biology Expert Secure Success
Client’s Testimonial:
"It was helpful to me when I was deciding to pursue O1 and EB1.”
On August 15th, 2025, and March 17th, 2026, we received O-1A (Individuals with Extraordinary Ability or Achievement) and EB-1A (Alien of Extraordinary Ability) approvals for a Research Associate in the Field of Molecular Biology (Approval Notice).
General Field: Molecular Biology
Position at the Time of Case Filing: Research Associate
Country of Origin: India
State of Residence at the Time of Filing: Virginia
Approval Notice Date: August 15th, 2025, and March 17th, 2026
Processing Time: 3 months, 13 days (O-1A) (Premium Processing Requested + RFE Response); 15 days (EB-1A) (Premium Processing Requested)
Case Summary:
An O-1A and an EB-1A were recently approved for a highly accomplished researcher. The O-1A was approved in just over 3 months following a successful RFE response prepared by our expert team, and the subsequent EB-1A petition was approved in just 15 days. Both petitions were filed under Premium Processing.
Research Leadership and Global Recognition
Currently working as a research associate in the field of molecular biology, the client holds a Ph.D. in biochemistry and molecular and cellular biology and has established deep expertise as one of the leading specialists in preclinical drug discovery, nanomedicine, and targeted therapeutics.
The client's scholarly record reflects a rare combination of productivity, impact, and scientific leadership:
- 10 peer-reviewed journal articles (1 first-authored), 3 conference abstracts (1 first-authored), 1 book chapter
- 345 citations from researchers across at least 42 countries
- At least 21 completed peer reviews for high-impact journals
- Funding source: the Defense Threat Reduction Agency, the National Foundation for Cancer Research, and the National Cancer Institute
Expert Endorsements
To build both the O-1A and EB-1A petitions, our firm included four expert recommendation letters from internationally recognized scientists. These experts represent elite institutions across the United States. One expert stated:
"Throughout [Client]’s career, [Client] has made significant contributions to groundbreaking projects that have advanced our understanding of molecular biology related to nerve agent antidotes."
O-1A & EB-1A Approvals and Outlook
We are honored to have supported this outstanding researcher and look forward to witnessing continued advances in cancer nanomedicine, chemical threat countermeasures, and pediatric neuro-oncology that will save lives and strengthen U.S. scientific leadership for years to come.